Results 41 to 50 of about 2,940,166 (197)
Beta-lactam-specific resistant mutants of Staphylococcus aureus [PDF]
In an approach to understanding the origin of methicillin resistance in clinical isolates of staphylococci, a series of Staphylococcus aureus mutants resistant to various beta-lactam antibiotics were isolated in the laboratory by antibiotic selection. Mutants with low- and intermediate-level resistance showed considerable specificity for the particular
TONIN, ENRICO ANGELO, TOMASZ A.
openaire +3 more sources
The Relationship between Antimicrobial Use and Antimicrobial Resistance in Europe
In Europe, antimicrobial resistance has been monitored since 1998 by the European Antimicrobial Resistance Surveillance System (EARSS). We examined the relationship between penicillin nonsusceptibility of invasive isolates of Streptococcus pneumoniae (an
Stef L.A.M. Bronzwaer +8 more
doaj +1 more source
Ceftriaxone-resistant salmonella enterica serotype Newport, France. [PDF]
The multidrug-resistant (MDR) Salmonella enterica serotype Newport strain that produces CMY-2 beta-lactamase (Newport MDR-AmpC) was the source of sporadic cases and outbreaks in humans in France during 2000-2005.
Delauné, Aurélia +30 more
core +1 more source
Beta-lactamase induction and cell wall metabolism in Gram-negative bacteria
Production of beta-lactamases, the enzymes that degrade beta-lactam antibiotics, is the most widespread and threatening mechanism of antibiotic resistance.
Ximin eZeng, Jun eLin
doaj +1 more source
Beta-lactam antibiotics are widely used to treat bacterial infections, but their efficacy is compromised by resistance mechanisms such as the production of beta-lactamases.
Karina Klycheva +5 more
doaj +1 more source
Management of Beta-Lactam Antibiotics Allergy: A Real-Life Study
Beta-lactam allergy is a common problem in everyday medical practice and is recognized as a major public health issue. Carrying this label frequently leads to the avoidance of all beta-lactam antibiotics, favoring the use of other less preferred classes ...
Sarah Iuliano +13 more
doaj +1 more source
Pseudomonas aeruginosa encodes the beta-lactamase AmpC, which promotes resistance to beta-lactam antibiotics. Expression of ampC is induced by anhydro-muropeptides (AMPs) released from the peptidoglycan (PG) cell wall upon beta-lactam treatment. AmpC can
Joël Gyger +4 more
doaj +1 more source
Resistance of Pseudomonas aeruginosa to new beta-lactamase-resistant beta-lactams [PDF]
An isogenic set of mutants of Pseudomonas aeruginosa, altered in permeability or permeability plus constitutive production of beta-lactamase, was examined for susceptibility to newer beta-lactam antibiotics. Kinetic data on the chromosomal beta-lactamase and susceptibility studies for the test beta-lactams indicate that permeability was the major ...
A J, Godfrey, L E, Bryan
openaire +2 more sources
Mutations in beta-lactam resistance determining regions and beta lactam resistance profiles.
Mutations in beta-lactam resistance determining regions and beta lactam resistance profiles.
Ajay Kumar Vijay (5802035) +4 more
core +1 more source
Approaches to Testing Novel β-Lactam and β-Lactam Combination Agents in the Clinical Laboratory
The rapid emergence of multi-drug resistant Gram-negative pathogens has driven the introduction of novel β-lactam combination agents (BLCs) to the antibiotic market: ceftolozane-tazobactam, ceftazidime-avibactam, meropenem-vaborbactam, imipenem ...
Carmella Russo, Romney Humphries
core +1 more source

